The Scientist

» award, microbiology and disease/medicine

Most Recent

A needle-free alternative to the finger-prick test would be a godsend for many sufferers of diabetes, but the industry has yet to clear the technological hurdles.

1 Comment

Spark Therapeutics’s Luxturna would be the first approved therapy in the U.S. that replaces or repairs a defective gene inherited from one’s parents.

1 Comment

image: Opinion: Microbiology Needs More Math

Opinion: Microbiology Needs More Math

By | October 12, 2017

Empirical data and humans’ biased interpretations can only get so far in truly understanding life at the microscale.

2 Comments

image: Cesarean Section Results in Heavier Mouse Pups

Cesarean Section Results in Heavier Mouse Pups

By | October 11, 2017

Vaginal birth leads to changes in the development of offsprings’ microbiomes not seen among mice born via C-section, which researchers suspect might contribute to the weight differences.

0 Comments

Combined transcription and genome data from multiple tissues in hundreds of human donors reveal links between genotype and gene expression across the body.

1 Comment

image: Plague Ravaging Madagascar

Plague Ravaging Madagascar

By | October 10, 2017

Nearly four dozen people have died.

0 Comments

image: Prizes Bigger than the Nobel

Prizes Bigger than the Nobel

By | October 5, 2017

The Nobel Prize may garner the most attention, but there are other biomedical awards at least as lucrative.

0 Comments

Tissue recipients were treated as “guinea pigs,” says investigation leader.

0 Comments

Mice receiving the treatment produced their own monoclonal antibodies and survived infection with the life-threatening pathogen Pseudomonas aeruginosa.

2 Comments

image: Giants of Circadian Biology Win Nobel Prize

Giants of Circadian Biology Win Nobel Prize

By | October 2, 2017

The award in Physiology or Medicine goes to chronobiologists Jeffrey Hall, Michael Rosbash, and Michael Young.

1 Comment

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Effects of Neanderthal DNA on Modern Humans
  3. Flux and Uncertainty in the CRISPR Patent Landscape
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech